Articles On Capitol Health (ASX:CAJ)

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Greg Peel Pending MRI deregulation is behind the now approved merger of Integral Diagnosti...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US Equities had a weak session, but nothing like the growth stocks sell-off that occ...

Integral Diagnostics (ASX:IDX), which operates diagnostic imaging services in Australia and New Zealand, has secured clearance from the Australian Competition and Consumer Commission (ACCC) for its proposed acquisition of Capitol Health (AS...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

Highlights ASX 200 closes 0.1% lower at 8,436.2 after early losses. Webjet Group WEB and Maas Group MGH post strong rallies. Star Entertainment SGR remains flat after a downgrade. The Australian share market ended Friday's trading...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

Jarden upgrades Integral Diagnostics after merger insights The broker highlights growth opportunities in imaging sector Australia’s deregulation boosts MRI access and revenue potential   The imaging sector is by no means the sexiest part...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

  US stocks jumped overnight, with the Dow Jones Industrial Average and the S&P 500 rising to new all-time highs, as traders cheered the Federal Reserve’s Wednesday decision to lower interest rates by half a percentage point. The 30-sto...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8210.00 + 73.00 0.90% S&P ASX 200 8191.90 +...

US stocks jumped overnight, with the Dow Jones Industrial Average and the S&P 500 rising to new all-time highs, as traders cheered the Federal Reserve’s Wednesday decision to lower interest rates by half a percentage point. The 30-stock...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

ASX healthcare stocks showed mixed results following the release of their most recent financials on Tuesday. Three companies in particular stand out, with two finishing in the green and one in the red. Integral Diagnostics Ltd (ASX: I...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ACF)) - Acrow...

As the 2024 fiscal year reporting season progresses, several key players across different sectors have revealed their financial performance, showcasing a mix of resilience and challenges. Diagnostic imaging provider Capitol Health, energy c...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7995.00 + 30.00 0.38% S&P ASX 200 8010.50 +...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

Highlights:  ASX 200 futures fall 1.09%, mirroring losses in major US indices and mixed global economic updates.  Big Tech stocks showed mixed results overnight, with Meta and Nvidia gaining, while Apple, Alphabet, and Amazon decline...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

Looking for exposure to the healthcare sector in FY 2025? If you are, then check out the three ASX shares listed below. They have just been tipped as Bell Potter's top healthcare stocks to buy now: Aroa Biosurgery Ltd (ASX: ARX) Aroa Biosu...

World Overnight SPI Overnight 7775.00 + 26.00 0.34% S&P ASX 200 7759.60 – 23.40 – 0.30% S&P500 5482.87 + 4.97 0.09% Nasdaq Comp 17858.68 + 53.53 0.30% DJIA 39164.06 + 36.26 0.09% S&P500 VIX 12.24 – 0.31 – 2.47% U...

The S&P/ASX 200 Index (ASX: XJO) is having a tough time on Wednesday after a stronger than expected inflation reading. In afternoon trade, the benchmark index is down 1% to 7,758.4 points. Four ASX shares that are not letting that hold...

Race Oncology Ltd (ASX: RAC) shares burst out of the gates on Wednesday morning. In early trade, the ASX healthcare stock was up as much as 15% to $1.96. The clinical stage biopharmaceutical company's shares have eased back a touch since th...

With the S&P/ASX 200 Health Care Index (ASX: XHJ) dipping slightly into the red on Wednesday, it's been a different story for three individual ASX healthcare shares. Pro Medicus Limited (ASX: PME), Race Oncology Ltd (ASX: RAC), and...

S&P/ASX 200 Index (ASX: XJO) gold stocks enjoyed a blistering rally from late February through to late May this year. That rally was driven by a surge in the gold price. On 28 February, the yellow metal was trading for US$2,030 per oun...

The S&P/ASX 200 Index (ASX: XJO) is back on form on Tuesday and storming higher. In afternoon trade, the benchmark index is up 0.95% to 7,773.6 points. Four ASX shares that are rising more than most today are listed below. Here's why t...

The S&P/ASX All Ordinaries Index (ASX: XAO) is up 0.76% to 8,003.8 points in early trading on Tuesday. As reported in The Australian, 3 All Ords stocks have just gained buy ratings from top brokers. Let's check them out. Capst...

Integral Diagnostics and Capitol Health have agreed to join forces and create a 155-clinic diagnostic imaging company.

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. At the time of writing, the benchmark index is down 0.15% to 7,711.6 points. Four ASX shares that are falling more than most today are listed...

The market may be edging lower on Monday but that hasn't stopped one ASX All Ords stock from rocketing. In morning trade, the Capitol Health Ltd (ASX: CAJ) share price is up 20% to 29.5 cents. Why is this ASX All Ords stock rocketing? Inves...

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

If you're looking for big returns, then it could be worth checking out the small side of the market. That's because in exchange for higher risk, investors have the potential for higher rewards. For example, the small cap ASX share in this a...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

  US markets kicked off the post Easter week by giving up ground on what was a winning month for March and a strong first quarter. New inflation data raised concerns that the Fed may struggle to hit its target of three rate cuts by the end...

A compilation of stories relating to the February 2024 corporate reporting season in Australia, including FNArena’s final balance for the season. Content (in chronological order of publication): -Healthcare, REITs, Uranium & Banks-Rudi...

Capitol Health’s first half results exceeded brokers’ expectations with higher margins thanks largely to good cost control. -Brokers raise targets following Capitol Health’s first half results-The earnings margin increased by 200bps due to...

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now...

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

  US stocks fell for a second session Tuesday, as steep declines in major tech names such as Apple dragged the broader market further from the record highs recently reached. The Nasdaq Composite pulled back by 1.65 per cent to 15,939.59 as...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AGI)) - Ainsworth Game Technology ((ART)) - Airtasker ((ALX)) - Atlas Arteria ((AFG)) - Australian Finance Group ((CAJ)) - Capitol Health ((CLU)) - Cluey ((DOC)) - Docto...

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

FNArena's dedicated ESG Focus news section zooms in on matters Environmental, Social & Governance (ESG) that are increasingly guiding investors preferences and decisions globally. For more news updates, past and future: https://www.fnar...

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...